# PERSPECTIVE: Beyond RAG — AI-Driven Knowledge Synthesis for Cross-Domain Translation

---

## What We've Actually Built

This system is often described as "RAG" (Retrieval-Augmented Generation), but that undersells its purpose and architecture. RAG is a **component** of the interface layer, but the core intellectual contribution is something more ambitious: **an AI-driven knowledge synthesis platform for systematic cross-domain translation**.

---

## The Three Layers

### Layer 1: Knowledge Extraction (Beyond RAG)
The `extract_protocols.py` + `protocols` table structure is **not RAG**. It's:
- **Structured knowledge extraction** — pulling *typed facts* (not just text chunks) from literature
- **Cross-document synthesis** — the same protocol mentioned in 5 papers becomes one canonical record with accumulated evidence
- **Semantic enrichment** — the LLM assesses domain-specific transferability constraints, which aren't stated in the source text

This is closer to **knowledge graph construction** or **ontology population** than retrieval. We're building a queryable database of *facts about protocols*, not just a searchable corpus of *papers*.

### Layer 2: Gap Analysis (Computational Comparative Research)
When we add the veterinary corpus and compute medical:veterinary cluster ratios, we're doing **cross-domain comparative analysis**:
- Identifying **knowledge gaps** (dense medical literature, sparse veterinary)
- Quantifying **transferability** (what medical protocols have no vet analog?)
- Highlighting **research opportunities** (where should vet diagnostics invest?)

This is **computational research synthesis**. The output isn't "here's what paper X says" (RAG), it's "here's what the entire field knows, and here's where it's silent."

### Layer 3: Contextual Retrieval (RAG+)
When `query_kb.py` eventually reports:
> *"mNGS from CSF exists in medical practice (8 papers, sensitivity 85-92%), but no veterinary equivalent found. Gap score: 0.95. Medical obstacles (cost, turnaround) amplified in vet settings due to…"*

That's **RAG enhanced with meta-knowledge**. The retrieval isn't just finding chunks — it's interpreting them through the lens of the gap analysis and protocol database.

---

## The Analogy That Fits

| System Type | What It Does | Example |
|-------------|--------------|---------|
| **RAG** | Librarian who fetches relevant books and quotes them | "Here's what Smith 2020 says about mNGS…" |
| **This system** | Research synthesis engine that builds a structured map of a field and identifies frontiers | "Medical field has validated 12 NGS protocols; veterinary field has 2. Here are the 10 gaps, ranked by feasibility." |

---

## In Academic Terms

If published, this would be titled:

**"A cross-domain knowledge synthesis platform for diagnostic protocol translation using LLM-assisted structured extraction and vector-based gap analysis"**

Or more colloquially:

**"A tool to systematically answer: What does Domain A know that Domain B doesn't, and how hard would it be to transfer that knowledge?"**

RAG is the *UI layer* (how users interact with the knowledge). The deeper contribution is the **protocol extraction schema** + **gap scoring methodology** + **transferability assessment framework**.

---

## Why This Matters

Most RAG systems assume the user already knows what questions to ask. This is different:

- **RAG:** "Tell me about mNGS for CSF" → retrieves papers mentioning it
- **This system:** "Show me all NGS diagnostic gaps between medical and veterinary practice" → computes answer from structured knowledge

The latter requires:
1. Extracting protocols as *structured entities* (not text)
2. Linking them across papers (deduplication + evidence accumulation)
3. Comparing corpora (gap scores)
4. Assessing transferability (domain-specific constraints)

That's **knowledge base construction** + **comparative analysis** + **decision support**, not just retrieval.

---

## The Philosophical Shift

**RAG asks:** *"What do these documents say?"*

**This system asks:** *"What does this field know, what's missing, and what's transferable?"*

The former is **information retrieval**. The latter is **knowledge synthesis for translational research**.

We're not building a better search engine. We're building a tool to **accelerate cross-domain knowledge transfer** — which is a much harder and more valuable problem.

---

## Generalization: AI-Driven Knowledge Synthesis as a Translational Research Tool

### The Core Insight

The architecture we've developed — structured protocol extraction + cross-corpus gap analysis + transferability scoring — is **domain-agnostic**. It solves a fundamental problem in translational research:

> *"Field A has developed methods/technologies/protocols that Field B needs, but the knowledge transfer is bottlenecked by manual literature review and domain expertise barriers."*

### Example Applications Beyond Medical→Veterinary NGS

#### 1. Oncology: Liquid Biopsy Translation Across Cancer Types
**Scenario:** A company developing liquid biopsy tests for lung cancer wants to learn from progress in colorectal cancer (CRC), where circulating tumor DNA (ctDNA) assays are more mature.

**System adaptation:**
- **Domain A (source):** CRC liquid biopsy literature (protocols for ctDNA detection, methylation markers, fragmentation patterns)
- **Domain B (target):** Lung cancer liquid biopsy literature
- **Protocol schema:** Detection modality (ddPCR, NGS, qPCR), biomarker class (mutations, methylation, fragmentomics), specimen type (plasma, serum), sensitivity/specificity
- **Gap analysis:** Which CRC biomarkers have no lung equivalent? Which assay platforms are validated in CRC but not lung?
- **Transferability scoring:** Adjust for tumor biology differences (mutation rates, shedding kinetics), specimen compatibility, regulatory pathway

**Output:** *"CRC field has validated 8 methylation-based ctDNA assays with 85%+ sensitivity. Lung cancer literature mentions methylation in 12 papers but no validated clinical assays. Gap score: 0.72. Key obstacle: different methylation profiles between adenocarcinoma subtypes. Transferability: 2/3 (feasible with biomarker re-optimization)."*

#### 2. Materials Science: Battery Chemistries from Automotive to Grid Storage
**Scenario:** Grid-scale energy storage developers want to adapt lithium-ion chemistries proven in electric vehicles.

**System adaptation:**
- **Domain A:** Automotive battery literature (NMC, LFP, solid-state chemistries)
- **Domain B:** Grid storage literature
- **Protocol schema:** Chemistry type, energy density, cycle life, thermal stability, cost per kWh
- **Gap analysis:** Which automotive chemistries have no grid-scale implementations?
- **Transferability scoring:** Adjust for different constraints (grid allows larger/heavier packs, needs 20+ year lifespan vs 10, different thermal management)

**Output:** *"LFP chemistry validated in 150+ automotive studies (avg 3000 cycles, $120/kWh). Grid storage corpus: 8 papers, no commercial deployments. Gap score: 0.94. Key obstacle: automotive cycle life insufficient for 20-year grid requirement. Transferability: 1/3 (needs fundamental chemistry modification)."*

#### 3. Drug Delivery: Formulation Techniques from Oncology to Gene Therapy
**Scenario:** Gene therapy companies want to learn from decades of nanoparticle formulation research in cancer drug delivery.

**System adaptation:**
- **Domain A:** Oncology nanoparticle delivery (liposomes, PEGylation, targeted ligands)
- **Domain B:** Gene therapy delivery (AAV, LNP, electroporation)
- **Protocol schema:** Delivery vehicle, cargo type (small molecule vs mRNA vs DNA), tissue targeting, immunogenicity
- **Gap analysis:** Which oncology formulation strategies have been adapted for gene therapy? Which haven't?
- **Transferability scoring:** Adjust for cargo size differences (small molecules vs plasmids), immune response constraints, manufacturing scalability

**Output:** *"PEGylation reduces immune clearance in 200+ oncology studies. Gene therapy literature: 45 papers mention PEGylation, 3 clinical trials. Gap score: 0.68. Key obstacle: PEG may reduce transfection efficiency for large nucleic acids. Transferability: 2/3 (requires optimization of PEG density/length)."*

#### 4. Agricultural Biotech: CRISPR Applications from Medicine to Crop Engineering
**Scenario:** Agricultural companies want to adapt CRISPR delivery and editing strategies proven in human therapeutics.

**System adaptation:**
- **Domain A:** Clinical CRISPR literature (delivery vehicles, off-target mitigation, editing efficiency)
- **Domain B:** Plant genome editing literature
- **Gap analysis:** Which clinical delivery methods (LNP, AAV, RNP) have crop analogs? Which editing strategies (base editing, prime editing) are validated in plants?
- **Transferability scoring:** Adjust for organism differences (plant cell walls, regeneration requirements, regulatory pathways)

**Output:** *"Base editing shows 60%+ efficiency in 80+ clinical studies. Plant literature: 12 papers, 4 crops tested. Gap score: 0.81. Key obstacle: plant cell wall limits delivery efficiency; regeneration protocol needed post-edit. Transferability: 1/3 (requires new delivery vehicle development)."*

---

### The Pattern: AI as Translational Research Catalyst

In every example, the system:

1. **Extracts structured knowledge** (protocols/methods/chemistries) from Domain A literature
2. **Maps the landscape** of Domain B to identify what exists vs what's missing
3. **Computes gap scores** (where is A's knowledge dense but B's sparse?)
4. **Assesses transferability** (what makes A→B translation hard? Biology? Scale? Regulation?)
5. **Prioritizes opportunities** (which gaps are most feasible to close?)

This is **not a search engine**. It's a **systematic research synthesis tool** that answers the question every translational scientist asks:

> *"What has been done in related fields that I should adapt, and what are the known obstacles to doing so?"*

Traditional approaches require:
- Expert knowledge of both domains (rare)
- Manual literature review (slow, incomplete)
- Trial-and-error adaptation (expensive)

**AI-driven knowledge synthesis** replaces months of literature review with:
- Automated protocol extraction at scale
- Quantitative gap analysis across thousands of papers
- LLM-powered transferability assessment (learns constraints from stated limitations/obstacles in source text)

---

### The Future: From Diagnostic Protocols to Universal Translational AI

The mNGS medical→veterinary system is a **proof of concept** for a generalizable architecture:

```
[Domain A Literature] → Extract(protocols) → Canonicalize → Store(KB_A)
[Domain B Literature] → Extract(protocols) → Canonicalize → Store(KB_B)
                              ↓
            Cluster(KB_A ∪ KB_B) → Compute(gaps) → Score(transferability)
                              ↓
            "Here are the 50 highest-value translational opportunities,
             ranked by feasibility and evidence quality."
```

The only domain-specific components are:
1. **Protocol schema** (what fields define a "method" in this domain?)
2. **Transferability rubric** (what makes translation hard? Biology? Scale? Cost? Regulation?)

Everything else — extraction, clustering, gap scoring, contextual retrieval — is **domain-agnostic AI infrastructure**.

---

### Why This Matters Now

AI changes the economics of translational research. Before LLMs:
- **Protocol extraction** required domain experts (expensive, slow)
- **Cross-domain mapping** required rare dual-expertise (oncologist + materials scientist?)
- **Transferability assessment** required experimental validation (trial-and-error)

With LLMs:
- **Protocol extraction** is automated (zero marginal cost per paper)
- **Cross-domain mapping** is computational (cluster embeddings, compute gaps)
- **Transferability assessment** is informed by LLM reasoning over stated obstacles in literature

The result: **translational research at scale**. A small team can now systematically map knowledge flows between fields, identify high-value gaps, and prioritize which cross-domain adaptations to pursue — without needing encyclopedic expertise in both domains.

---

### Characterization for Non-Technical Audiences

**What is this system?**

An **AI-powered knowledge synthesis platform** that reads thousands of scientific papers across two fields, extracts what methods/protocols each field has validated, identifies where one field is ahead of the other, and assesses how hard it would be to transfer that knowledge.

**What problem does it solve?**

Scientific fields often develop solutions to similar problems independently. Medical researchers develop a diagnostic test; veterinary researchers need the same test but don't know it exists in the medical literature (or know it exists but can't assess if it's adaptable). This system automates the discovery of those translational opportunities and flags the obstacles.

**What makes it different from a search engine?**

A search engine finds papers mentioning "liquid biopsy." This system answers:
- *"Which liquid biopsy methods exist in oncology but not in veterinary medicine?"*
- *"For each gap, what are the known obstacles to translation?"*
- *"Which gaps are most feasible to close given current technology?"*

It synthesizes knowledge across an entire field, not just retrieves individual papers.

**Who benefits?**

- **R&D teams** exploring new applications of existing technologies
- **Investors** identifying white-space opportunities in adjacent markets
- **Regulators** understanding how methods validated in one domain could apply to another
- **Academics** systematically reviewing cross-domain literature for meta-analyses

---

**In summary:** We've built a prototype of a generalizable AI tool for **accelerating knowledge transfer between scientific domains** — starting with NGS diagnostics, but applicable to any field where Domain A's progress could inform Domain B's challenges.

---

**Created:** 2026-02-19
**Context:** End-of-session synthesis discussion
**Related:** SESSION_CONTEXT.md (implementation details)
